Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Virata
Efficacy of an 8-Week Course of Sofosbuvir and Ledipasvir for the Treatment of HCV Infection in Selected HIV-infected Patients
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Related publications
Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV
Antiviral Therapy
Infectious Diseases
Pharmacology
Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1
Journal of Hepatology
Hepatology
Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure
Hepatology
Medicine
Hepatology
Budget Impact Analysis of Sofosbuvir-Based Regimens for the Treatment of Hiv/HCV Co-Infected Patients in Northern Italy: The Liguria Region Simulation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Randomised Clinical Trial: Sofosbuvir and Ledipasvir in Patients With Transfusion-Dependent Thalassaemia and HCV Genotype 1 or 4 Infection
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir
International Journal of Current Microbiology and Applied Sciences
Sofosbuvir and Velpatasvir: A Complete Pan-Genotypic Treatment for HCV Patients
Turkish Journal of Gastroenterology
Gastroenterology
